CS logo
small CS logo
Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda

Ijui, RS, Brazil
Pesquisa e desenvolvimento de produtos em Ijuí, Rio Grande do Sul

About Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Janssen Research & Development, LLC
5
Merck Sharp & Dohme LLC
2
NovoCure Ltd.
1
PharmaMar
1
Total Rows: 5

Clinical Trials at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


During the past decade, Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44334433220000000000Started TrialsCompleted Trails201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
2018-02-10
2024-10-30
Active, not recruiting
556
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases
2018-12-13
2022-12-03
Active, not recruiting
80
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
2018-12-27
2031-01-24
Active, not recruiting
1,240
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
2019-01-25
2027-02-19
Active, not recruiting
765
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
2019-06-11
2027-04-07
Recruiting
2,500
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
2019-04-22
2022-11-29
Completed
14,532
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "NovoCure Ltd." with 1 trials sponsored and "PharmaMar" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2NovoCure Ltd.: 1NovoCure Ltd.: 1PharmaMar: 1PharmaMar: 1

Created with Highcharts 11.1.0Top CollaboratorsAlliance FoundationTrials (AFT): 1Alliance FoundationTrials (AFT): 1Breast International Group: 1Breast International Group: 1Frontier Science &Technology ResearchFoundation, Inc.: 1Frontier Science &Technology ResearchFoundation, Inc.: 1Institut JulesBordet/Clinical TrialsSupport Unit (IJB/CTSU):1Institut JulesBordet/Clinical TrialsSupport Unit (IJB/CTSU):1

Clinical Trials Conditions at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


According to Clinical.Site data, the most researched conditions in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Lung Neoplasms" (1 trials). Many other conditions were trialed in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" in a lesser frequency.

Clinical Trials Intervention Types at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


Most popular intervention types in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are "Drug" (14 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (4 trials), "Amivantamab" (2 trials), "Tiragolumab" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


The vast majority of trials in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda" are 13 trials for "All" genders and 3 trials for "Male" genders.

Clinical Trials Status at Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


Currently, there are NaN active trials in "Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 8Active, not recruiting: 8Recruiting: 7Recruiting: 7Completed: 1Completed: 1

Departments of Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda


Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda has several departments that took part in Clinical trials: "Oncosite - Centro de Pesquisa Clinica Em Oncologia" - 2 trials
Departments List
Total Rows: 1